Literature DB >> 16103563

Secondary prevention with folic acid: results of the Goes extension study.

A Liem, G H Reynierse-Buitenwerf, A H Zwinderman, J W Jukema, D J van Veldhuisen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16103563      PMCID： PMC1769062          DOI： 10.1136/hrt.2004.035030

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

Authors: 
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

2.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

Authors:  David S Wald; Malcolm Law; Joan K Morris
Journal:  BMJ       Date:  2002-11-23

3.  Secondary prevention with folic acid: effects on clinical outcomes.

Authors:  Anho Liem; Giny H Reynierse-Buitenwerf; Aeilko H Zwinderman; J Wouter Jukema; Dirk J van Veldhuisen
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

4.  Sources of diagnostic inaccuracy of conventional versus new diagnostic criteria for myocardial infarction in an unselected UK population with suspected cardiac chest pain, and investigation of independent prognostic variables.

Authors:  J Trevelyan; E W A Needham; S C H Smith; R K Mattu
Journal:  Heart       Date:  2003-12       Impact factor: 5.994

5.  Folate therapy and in-stent restenosis after coronary stenting.

Authors:  Helmut Lange; Harry Suryapranata; Giuseppe De Luca; Caspar Börner; Joep Dille; Klaus Kallmayer; M Noor Pasalary; Eberhard Scherer; Jan-Henk E Dambrink
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245
  5 in total
  20 in total

1.  Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis.

Authors:  Meng Lee; Keun-Sik Hong; Shen-Chih Chang; Jeffrey L Saver
Journal:  Stroke       Date:  2010-04-22       Impact factor: 7.914

Review 2.  Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence.

Authors:  David S Wald; Nicholas J Wald; Joan K Morris; Malcolm Law
Journal:  BMJ       Date:  2006-11-25

3.  A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease.

Authors:  Jae Hee Kang; Nancy Cook; JoAnn Manson; Julie E Buring; Christine M Albert; Francine Grodstein
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

4.  Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.

Authors:  William G Christen; Robert J Glynn; Emily Y Chew; Christine M Albert; Joann E Manson
Journal:  Arch Intern Med       Date:  2009-02-23

Review 5.  The association between B vitamins supplementation and adverse cardiovascular events: a meta-analysis.

Authors:  Wen-Feng Li; Dan-Dan Zhang; Ji-Tian Xia; Shan-Fan Wen; Jun Guo; Zi-Cheng Li
Journal:  Int J Clin Exp Med       Date:  2014-08-15

Review 6.  Homocysteine-lowering interventions for preventing cardiovascular events.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Mark Dayer
Journal:  Cochrane Database Syst Rev       Date:  2017-08-17

7.  Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome.

Authors:  Gideon R Hajer; Yolanda van der Graaf; Jobien K Olijhoek; Marianne C Verhaar; Frank L J Visseren
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

Review 8.  Homocysteine lowering interventions for preventing cardiovascular events.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Georgia Salanti
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

9.  Does folate therapy reduce the risk of coronary restenosis?

Authors:  E S van Hattum; P A Doevendans; F L Moll
Journal:  Neth Heart J       Date:  2007-01       Impact factor: 2.380

10.  The effects of folic acid and nitric oxide synthase inhibition on coronary flow and oxidative stress markers in isolated rat heart.

Authors:  Dragan Djurić; Ana Vusanović; Vladimir Jakovljević
Journal:  Mol Cell Biochem       Date:  2006-11-30       Impact factor: 3.842
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.